What is the Dash diet and why is it a valuable ally for the heart and mind?

An almost taken-for-granted gesture marks the days of millions of people: measuring blood pressure. Yet, those values not only tell the state of the heart and blood vessels but could also foreshadow the fate of our memory.

A large study, published on February 23, 2026 in JAMA Neurology, has indeed highlighted a strong link between an “anti-pressure” diet and the preservation of cognitive abilities over time. The protagonist of this evidence is the DASH diet (Dietary Approaches to Stop Hypertension), which proves to be a formidable shield against cognitive decline.

The analysis involved over 159,000 American adults followed for decades in three large epidemiological cohorts, including the Nurses’ Health Study and the Health Professionals Follow-Up Study.

Comparing six different healthy dietary patterns, DASH emerged as the most effective: participants who adhered to it more rigorously showed a subjective risk of cognitive decline up to 41% lower than those who followed it less closely.

Crucial, according to the authors, is the “golden window” between ages 45 and 54, when adopting correct nutritional habits seems to maximize benefits for the brain.

Designed in the United States in the late 1990s to reduce blood pressure without immediately resorting to medication, DASH is not a trend but a sustainable lifestyle. Its cornerstone is a large presence of vegetables, fruits, and whole grains, accompanied by low-fat dairy, fish, poultry, legumes, and nuts. At the same time, it calls for a significant reduction in sodium (up to 2,300 mg per day, with an ideal goal of 1,500 mg), added sugars, saturated fats, and red or processed meats.

Researchers hypothesize that cognitive benefits arise from the protection of the entire vascular and metabolic system. Hypertension is indeed a known risk factor for dementia and micro-brain lesions. By reducing sodium and increasing key nutrients such as potassium, magnesium, and omega-3s, the dietary pattern improves endothelial function and counters inflammation and insulin resistance, creating a biological environment favorable to the safeguarding of synapses in the long term.

Acting in midlife is crucial: it is at this stage that modifiable risk factors, such as high blood pressure and dysmetabolism, tend to consolidate. Intervening between 45 and 54 years means doing so when the brain maintains a high plasticity and a greater ability to compensate for future damage.